The DOI matches its Crossref record.
Natural history of amyotrophic lateral sclerosis in a database population Validation of a scoring system and a model for survival prediction
Abstract
Over 1200 patients with motor neuron disease have been carefully diagnosed, followed, and included in a detailed database delineating characteristics of the disease. Of these patients, 831 were identified as exhibiting typical, sporadic amyotrophic lateral sclerosis (ALS). The progression of the disease in these patients has been followed with our scoring system, and the ALS score was verified as a significant covariate of survival. Age at first symptom, delay from first symptom to entering ALS clinic, and rate of change of respiratory function were also identified as significant covariates of survival. These measures, applied to the Cox proportional hazards model, were used to develop a mathematical model for prediction of survival time in ALS, which proved highly accurate for the 80% of patients at intermediate risk. For those patients, a second model was developed which accurately predicts, after an initial period of observation, the time over which ALS patients will decline a set number of points in total ALS score. Such validation permits initial trials for drug therapies in ALS by comparison of relatively small groups of treated patients to this historical control group, based on the model of predicted time to a particular decrement in total ALS score.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Prognostic factors in ALS: A critical review
Chiò, A., Logroscino, G., Hardiman, O., Swingler, R., Mitchell, D., Beghi, E., Traynor, B. G., & On Behalf of the Eurals Consortium (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960802566824 · Cited by 1,172
The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Andersen, P. M., Abrahams, S., Borasio, G. D., de Carvalho, M., Chio, A., Van Damme, P., Hardiman, O., Kollewe, K., Morrison, K. E., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03501.x · Cited by 1,117
Clinical genetics of amyotrophic lateral sclerosis: what do we really know?
Andersen, P. M., & Al-Chalabi, A. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.150 · Cited by 687
Mitchell, J., & Borasio, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60944-1 · Cited by 561
Controversies and priorities in amyotrophic lateral sclerosis
Turner, M. R., Hardiman, O., Benatar, M., Brooks, B. R., Chio, A., de Carvalho, M., Ince, P. G., Lin, C., Miller, R. G., Mitsumoto, H., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70036-x · Cited by 541
Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis
Cudkowicz, M. E., McKenna‐Yasek, D., Sapp, P. E., Chin, W., Geller, B., Hayden, D. L., Schoenfeld, D. A., Hosler, B. A., Horvitz, H. R., & Brown, R. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410212 · Cited by 533
Nutritional status is a prognostic factor for survival in ALS patients
Desport, J. C., Preux, P. M., Truong, T. C., Vallat, J. M., Sautereau, D., & Couratier, P. (1999) · Neurology · doi:10.1212/wnl.53.5.1059 · Cited by 486
Prognosis in amyotrophic lateral sclerosis: A population-based study
del Aguila, M. A., Longstreth, W. T., McGuire, V., Koepsell, T. D., & van Belle, G. (2003) · Neurology · doi:10.1212/01.wnl.0000049472.47709.3b · Cited by 469
Beers, D. R., Henkel, J. S., Zhao, W., Wang, J., Huang, A., Wen, S., Liao, B., & Appel, S. H. (2011) · Brain · doi:10.1093/brain/awr074 · Cited by 424
Self-citationNewman, R., Vilardell, N., Clavé, P., & Speyer, R. (2016) · Dysphagia · doi:10.1007/s00455-016-9696-8 · Cited by 396
Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis
Lyall, R. A. (2001) · Brain · doi:10.1093/brain/124.10.2000 · Cited by 384
Traynor, B. J., Codd, M. B., Corr, B., Forde, C., Frost, E., & Hardiman, O. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.8.1171 · Cited by 380
Effects of gender in amyotrophic lateral sclerosis
McCombe, P. A., & Henderson, R. D. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.11.010 · Cited by 379
Mitochondria: A central target for sex differences in pathologies
Ventura-Clapier, R., Moulin, M., Piquereau, J., Lemaire, C., Mericskay, M., Veksler, V., & Garnier, A. (2017) · Clinical Science · doi:10.1042/cs20160485 · Cited by 371
Lai, E. C., Felice, K. J., Festoff, B. W., Gawel, M. J., Gelinas, D. F., Kratz, R., Murphy, M. F., Natter, H. M., Norris, F. H., Rudnicki, S. A., et al. (1997) · Neurology · doi:10.1212/wnl.49.6.1621 · Cited by 361
A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia
Morita, M., Al-Chalabi, A., Andersen, P. M., Hosler, B., Sapp, P., Englund, E., Mitchell, J. E., Habgood, J. J., de Belleroche, J., Xi, J., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000200048.53766.b4 · Cited by 357
Regulatory T‐lymphocytes mediate amyotrophic lateral sclerosis progression and survival
Henkel, J. S., Beers, D. R., Wen, S., Rivera, A. L., Toennis, K. M., Appel, J. E., Zhao, W., Moore, D. H., Powell, S. Z., & Appel, S. H. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201544 · Cited by 353
Self-citationRate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis
Byrne, S., Walsh, C., Lynch, C., Bede, P., Elamin, M., Kenna, K., McLaughlin, R., & Hardiman, O. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.224501 · Cited by 351
Inflammation in ALS/FTD pathogenesis
McCauley, M. E., & Baloh, R. H. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1933-9 · Cited by 341
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis
Borasio, G. D., Robberecht, W., Leigh, P. N., Emile, J., Guiloff, R. J., Jerusalem, F., Silani, V., Vos, P. E., Wokke, J. H. J., Dobbins, T., et al. (1998) · Neurology · doi:10.1212/wnl.51.2.583 · Cited by 340
Role of Oxidative Stress and Antioxidants in Neurodegenerative Diseases
Rao, A. V., & Balachandran, B. (2002) · Nutritional Neuroscience · doi:10.1080/1028415021000033767 · Cited by 336
Fratta, P., Mizielinska, S., Nicoll, A. J., Zloh, M., Fisher, E. M. C., Parkinson, G., & Isaacs, A. M. (2012) · Scientific Reports · doi:10.1038/srep01016 · Cited by 333
Cutler, R. G., Pedersen, W. A., Camandola, S., Rothstein, J. D., & Mattson, M. P. (2002) · Annals of Neurology · doi:10.1002/ana.10312 · Cited by 323
Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients
Forsberg, K., Jonsson, P. A., Andersen, P. M., Bergemalm, D., Graffmo, K. S., Hultdin, M., Jacobsson, J., Rosquist, R., Marklund, S. L., & Brännström, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011552 · Cited by 320
Is SOD1 loss of function involved in amyotrophic lateral sclerosis?
Saccon, R. A., Bunton-Stasyshyn, R. K. A., Fisher, E. M. C., & Fratta, P. (2013) · Brain · doi:10.1093/brain/awt097 · Cited by 317
Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS)
Grad, L. I., Rouleau, G. A., Ravits, J., & Cashman, N. R. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024117 · Cited by 316
Elam, J. S., Taylor, A. B., Strange, R., Antonyuk, S., Doucette, P. A., Rodriguez, J. A., Hasnain, S. S., Hayward, L. J., Valentine, J. S., Yeates, T. O., et al. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb935 · Cited by 316
Siklós, L., Engelhardt, J., Harati, Y., Smith, R. G., Joó, F., & Appel, S. H. (1996) · Annals of Neurology · doi:10.1002/ana.410390210 · Cited by 310
Self-citationCorticospinal tract degeneration in the progressive muscular atrophy variant of ALS
Ince, P. G., Evans, J., Knopp, M., Forster, G., Hamdalla, H. H. M., Wharton, S. B., & Shaw, P. J. (2003) · Neurology · doi:10.1212/01.wnl.0000058901.75728.4e · Cited by 304
Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia
Elamin, M., Phukan, J., Bede, P., Jordan, N., Byrne, S., Pender, N., & Hardiman, O. (2011) · Neurology · doi:10.1212/wnl.0b013e318214359f · Cited by 301
Incidence and prevalence of ALS in Ireland, 1995–1997: A population-based study
Traynor, B. J., Codd, M. B., Corr, B., Forde, C., Frost, E., & Hardiman, O. (1999) · Neurology · doi:10.1212/wnl.52.3.504 · Cited by 292
Andersen, P. M., Borasio, G. D., Dengler, R., Hardiman, O., Kollewe, K., Leigh, P. N., Pradat, P. ‐., Silani, V., & Tomik, B. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01351.x · Cited by 289
The anatomy and physiology of normal and abnormal swallowing in oropharyngeal dysphagia
Sasegbon, A., & Hamdy, S. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13100 · Cited by 287
Cedarbaum, J. M., & Stambler, N. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00237-2 · Cited by 284
A randomized sequential trial of creatine in amyotrophic lateral sclerosis
Jan Groeneveld, G., Veldink, J. H., van der Tweel, I., Kalmijn, S., Beijer, C., de Visser, M., Wokke, J. H. J., Franssen, H., & Berg, L. H. V. D. (2003) · Annals of Neurology · doi:10.1002/ana.10554 · Cited by 283
The epidemiology of motor neuron diseases: a review of recent studies
Worms, P. M. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00630-x · Cited by 278
Yoshihara, T., Ishigaki, S., Yamamoto, M., Liang, Y., Jun, Niwa, I., Takeuchi, H., Doyu, M., & Sobue, G. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00683.x · Cited by 275
Natural history and clinical features of the flail arm and flail leg ALS variants
Wijesekera, L. C., Mathers, S., Talman, P., Galtrey, C., Parkinson, M. H., Ganesalingam, J., Willey, E., Ampong, M. A., Ellis, C. M., Shaw, C. E., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000345041.83406.a2 · Cited by 275
Intermolecular transmission of superoxide dismutase 1 misfolding in living cells
Grad, L. I., Guest, W. C., Yanai, A., Pokrishevsky, E., O'Neill, M. A., Gibbs, E., Semenchenko, V., Yousefi, M., Wishart, D. S., Plotkin, S. S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102645108 · Cited by 274
Czaplinski, A. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.072660 · Cited by 273
Minute quantities of misfolded mutant superoxide dismutase‐1 cause amyotrophic lateral sclerosis
Jonsson, P. A., Ernhill, K., Andersen, P. M., Bergemalm, D., Brännström, T., Gredal, O., Nilsson, P., & Marklund, S. L. (2004) · Brain · doi:10.1093/brain/awh005 · Cited by 260
Smith, R. G., Henry, Y. K., Mattson, M. P., & Appel, S. H. (1998) · Annals of Neurology · doi:10.1002/ana.410440419 · Cited by 257
Self-citationAppel, S. H., Beers, D. R., & Henkel, J. S. (2010) · Trends in Immunology · doi:10.1016/j.it.2009.09.003 · Cited by 256
Self-citationGenetics of familial and sporadic amyotrophic lateral sclerosis
Gros-Louis, F., Gaspar, C., & Rouleau, G. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.01.004 · Cited by 255
ALSFRS-R score and its ratio: A useful predictor for ALS-progression
Kollewe, K., Mauss, U., Krampfl, K., Petri, S., Dengler, R., & Mohammadi, B. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.07.016 · Cited by 253
“This is in accordance with most of the previous studies [3,4,6–10,23].”
BackgroundResultInfluentialSexual differences in onset of disease and response to exercise in a transgenic model of ALS
Veldink, J. H., Bär, P. R., Joosten, E. A. J., Otten, M., Wokke, J. H. J., & van den Berg, L. H. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(03)00104-4 · Cited by 252
Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis.
Massman, P. J., Sims, J., Cooke, N., Haverkamp, L. J., Appel, V, & Appel, S. H. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.5.450 · Cited by 252
Self-citationDiagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis
Kühnlein, P., Gdynia, H.-J., Sperfeld, A.-D., Lindner-Pfleghar, B., Ludolph, A. C., Prosiegel, M., & Riecker, A. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0853 · Cited by 252
Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders
Pinares-Garcia, P., Stratikopoulos, M., Zagato, A., Loke, H., & Lee, J. (2018) · Brain Sciences · doi:10.3390/brainsci8080154 · Cited by 200
Autoimmune disease preceding amyotrophic lateral sclerosis: An epidemiologic study
Turner, M. R., Goldacre, R., Ramagopalan, S., Talbot, K., & Goldacre, M. J. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a6cc13 · Cited by 185
Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175
Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease
Dal Bello-Haas, V., & Florence, J. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005229.pub3 · Cited by 178
Zoccolella, S., Beghi, E., Palagano, G., Fraddosio, A., Guerra, V, Samarelli, V, Lepore, V, Simone, I. L., Lamberti, P., Serlenga, L., et al. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.118018 · Cited by 147
Genetic epidemiology of amyotrophic lateral sclerosis
Majoor‐Krakauer, D., Willems, P., & Hofman, A. (2003) · Clinical Genetics · doi:10.1046/j.0009-9163.2002.00001.x · Cited by 147
Burden, depression, and anxiety in caregivers of people with amyotrophic lateral sclerosis
Pagnini, F., Rossi, G., Lunetta, C., Banfi, P., Castelnuovo, G., Corbo, M., & Molinari, E. (2010) · Psychology, Health & Medicine · doi:10.1080/13548506.2010.507773 · Cited by 139
Association of apolipoprotein E ∈4 allele with bulbar-onset motor neuron disease
Al-Chalabi, A., Bakker, M. C., Shaw, C. E., Lloyd, C. M., Enayat, Z. E., Leigh, P. N., Sham, P. S., Ball, D. M., & Powell, J. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90343-8 · Cited by 114
Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis
Ilieva, H., Vullaganti, M., & Kwan, J. (2023) · BMJ · doi:10.1136/bmj-2023-075037 · Cited by 111
Living with motor neurone disease: lives, experiences of services and suggestions for change
Hughes, R. A., Sinha, A., Higginson, I., Down, K., & Leigh, P. N. (2005) · Health and Social Care in the Community · doi:10.1111/j.1365-2524.2005.00530.x · Cited by 105
CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model
Matsumoto, T., Imagama, S., Hirano, K., Ohgomori, T., Natori, T., Kobayashi, K., Muramoto, A., Ishiguro, N., & Kadomatsu, K. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.05.048 · Cited by 80
Diagnostic Delay in Amyotrophic Lateral Sclerosis
Gwathmey, K. G., Corcia, P., McDermott, C. J., Genge, A., Sennfält, S., de Carvalho, M., & Ingre, C. (2023) · European Journal of Neurology · doi:10.1111/ene.15874 · Cited by 76
Kim, H. J., Magranè, J., Starkov, A. A., & Manfredi, G. (2012) · Brain · doi:10.1093/brain/aws208 · Cited by 64
“Epidemiological studies indicate that males are at a higher risk to develop amyotrophic lateral sclerosis than females, and that this gender difference declines among older patients (Haverkamp et al., 1995).”
BackgroundPagnini, F., Phillips, D., Bosma, C. M., Reece, A., & Langer, E. (2015) · Psychology & Health · doi:10.1080/08870446.2014.982652 · Cited by 62
Information needs and information-seeking preferences of ALS patients and their carers
Abdulla, S., Vielhaber, S., Machts, J., Heinze, H.-J., Dengler, R., & Petri, S. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.932385 · Cited by 42
Apolipoprotein E ɛ4 in bulbar-onset motor neuron disease
Smith, R. G., Haverkamp, L. J., Case, S., Appel, V., & Appel, S. H. (1996) · The Lancet · doi:10.1016/s0140-6736(05)64502-3 · Cited by 37
Self-citationLuigetti, M., Quaranta, D., Conte, A., Piccininni, C., Lattante, S., Romano, A., Silvestri, G., Zollino, M., & Sabatelli, M. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/17482968.2012.692383 · Cited by 15
Metadata
- Authors
- Haverkamp, L. J., Appel, V., & Appel, S. H.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1995
- Volume
- 118
- Issue
- 3
- Pages
- 707-719
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2007478642
- Cited by
- 696
- References
- 0
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.